ArticleBlood2014
PKC-β as a therapeutic target in CLL: PKC inhibitor AEB071 demonstrates preclinical activity in CLL.
Dalia El-Gamal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
26 papers cite it
this papercites it
ArticleBlood2014
Dalia El-Gamal et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.